
Charles Stephen Foster MD
Cataract Related, Cornea & External Disease, Refractive Surgery, Uveitis
President and CEO, Massachusetts Eye Research and Surgery Institution (MERSI) Professor, Part-Time, Department of Ophthalmology at Harvard Medical School Founder and Chairman of the Board, Ocular Immunology and Uveitis Foundation
Join to View Full Profile
1440 Main StSte 201Waltham, MA 02451
Phone+1 781-891-6377
Fax+1 617-494-1430
Dr. Foster is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
- Massachusetts Eye and Ear Infirmary/Harvard Medical SchoolFellowship, Cornea, External Diseases, and Refractive Surgery, 1975 - 1977
- Harvard Medical SchoolFellowship, Ocular Immunology/Uveitis, 1975 - 1976
- Washington University/B-JH/SLCH ConsortiumResidency, Ophthalmology, 1972 - 1975
- Duke University HospitalInternship, Internal Medicine, 1969 - 1970
- Duke University School of MedicineClass of 1969
- Duke Universitycandidate, Immunology/Biochemistry, 1967 - 1968
- Duke UniversityB.S., Chemistry, With highest distinction, 1965
Certifications & Licensure
- MA State Medical License 1975 - 2025
- NY State Medical License 2006 - 2020
- FL State Medical License 2017 - 2019
- NC State Medical License 1969 - 1992
- MD State Medical License 1970 - 1988
- American Board of Ophthalmology Ophthalmology
Awards, Honors, & Recognition
- Life Fellow Award Academy of Ophthalmology, 2012
- CMS Meaningful Use Stage 1 Certification NextGen Ambulatory EHR, NextGen Healthcare, 2012-2013
- Most Compassionate Doctor Award Vitals, 2012
- Join now to see all
Clinical Trials
- Efficacy and Safety of H.P. ACTHAR GEL in Adults With Retinal Vasculitis Start of enrollment: 2017 Mar 22
Roles: Principal Investigator, Contact
Publications & Presentations
PubMed
- Effectiveness of Frequently Used TNF Inhibitors vs. Conventional Immunosuppressive Therapies for Noninfectious Uveitis.Sapna S Gangaputra, Craig W Newcomb, Gui-Shuang Ying, Kurt A Dreger, Tonetta Fitzgerald
Ocular Immunology and Inflammation. 2025-04-15 - Incidence and Outcome of Cataract in Eyes with Scleritis and Episcleritis.Michelle J Sun, Bernard A Rosner, Craig W Newcomb, Kurt A Dreger, Pichaporn Artornsombudh
Ocular Immunology and Inflammation. 2025-02-12 - Incidence and Outcomes of Cataract in Eyes with Ocular Cicatricial Pemphigoid.Pichaporn Artornsombudh, Maxwell Pistilli, Craig W Newcomb, C Stephen Foster, Douglas A Jabs
Ocular Immunology and Inflammation. 2025-02-05
Journal Articles
- Use of intravitreal rituximab for treatment of vitreoretinal lymphomaLarkin KL, Saboo US, Comer GM, Forooghian F, Mackensen F, Merrill P, Sen HN, Singh A, Essex RW, Lake S, Lim LL, Vasconcelos-Santos DV, Foster CS, Wilson DJ, Smith JR, British Journal of Ophthalmology, 1/1/2014
- Anterior chamber intraocular lens implantation in patients with a history of chronic uveitis: Five-year follow-upSuelves AM, Siddique SS, Schurko B, Foster CS, Journal of Cataract and Refractive Surgery, 1/1/2014
- Join now to see all
External Links
- Uveitis.orghttp://Www.uveitis.org
- MERSIhttp://Www.mersi.com
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: